What is PGT-A?

Preimplantation Genetic Testing for Aneuploidy, commonly known as PGT-A, is a genetic test performed on embryos created through in vitro fertilization (IVF) before they are transferred to the uterus. PGT-A examines embryos for chromosomal abnormalities, also known as aneuploidy, which can affect embryo development, pregnancy success, and the health of the resulting baby. By screening embryos for aneuploidy, PGT-A increases the chances of a successful IVF cycle and reduces the risk of miscarriage or genetic disorders.

Role of PGT-A in Fertility Treatment

PGT-A is a valuable tool in fertility treatment for patients who may be at higher risk of chromosomal abnormalities, such as women of advanced maternal age, couples with a history of recurrent miscarriage, and patients with previously unsuccessful IVF attempts. By identifying healthy embryos, PGT-A can improve IVF outcomes, allowing fertility specialists to select the embryos most likely to lead to a successful pregnancy.

Steps in Conducting PGT-A on Embryos

1.  IVF and Embryo Creation

The PGT-A process begins with standard IVF, in which eggs are retrieved from the ovaries and fertilized with sperm in a laboratory. Once the embryos begin to develop, they are monitored until they reach the blastocyst stage (typically around day 5 or 6).

2.  Biopsy of the Embryo

At the blastocyst stage, a few cells are carefully removed from the outer layer of the embryo, known as the trophectoderm, which will later develop into the placenta. This biopsy procedure does not harm the embryo and allows embryologists to examine the cells without impacting future development.

3.  Genetic Analysis of the Biopsy

The cells extracted during the biopsy are sent to a genetic laboratory, where they undergo detailed genetic testing to analyze all 23 pairs of chromosomes. The testing checks for missing or extra chromosomes (aneuploidy) that could affect pregnancy success.

4. Inserting the Laparoscope and Additional Instruments

The results of the PGT-A analysis are typically available within a week. Embryos are categorized as euploid (normal chromosomal count) or aneuploid (abnormal chromosomal count). The fertility specialist will review these results to determine which embryos are suitable for transfer.Once the examination and any necessary treatments are complete, the instruments are removed, and the gas is released from the abdomen. The incisions are then closed with stitches or surgical tape.

5. Embryo Transfer

Following the PGT-A test, a euploid embryo (one with a normal chromosomal count) is selected for transfer. This transfer can occur in a fresh cycle (immediately after testing) or a frozen cycle (embryos are frozen and thawed before transfer at a later date).

80% of couples achieve their dreams with IVFPULSE, enjoying successful deliveries at 40% less cost through top doctors—always with privacy and care.

Procedure Duration:

The PGT-A test is typically completed within a week, although the timeline may vary depending on the lab. The embryo transfer can be scheduled based on the results, either as a fresh or frozen cycle.

Purpose of PGT-A

Why PGT-A is Used in Fertility Treatments

  • Improving IVF Success Rates: PGT-A helps to identify embryos with a normal chromosomal count, which are more likely to implant successfully and develop into a healthy pregnancy.
  • Reducing the Risk of Miscarriage: Many miscarriages are caused by chromosomal abnormalities. By selecting chromosomally normal embryos, PGT-A reduces the likelihood of miscarriage.
  • Preventing Genetic Disorders:  Embryos with chromosomal abnormalities may lead to genetic disorders like Down syndrome, Turner syndrome, and others. Screening with PGT-A allows doctors to minimise this risk..
  • Optimising Embryo Selection for Transfer:  For patients producing multiple embryos, PGT-A provides valuable information to select the highest-quality embryo, helping to achieve pregnancy in fewer cycles and reducing the emotional and financial burden of repeated IVF attempts..

Guidelines for Patients Preparing for PGT-A

  • Consultation with a Genetic Counselor: Meeting with a genetic counselor can provide valuable information on what to expect from PGT-A, as well as insights into any genetic risks specific to the patient’s family history.
  • Understanding the Timeline and Costs: Patients should review the timeline for PGT-A and understand its associated costs, as these vary depending on the clinic and insurance coverage.
  • Discussion of Embryo Transfer Plans: Depending on PGT-A results, the embryo transfer may occur in the same cycle or in a later frozen cycle. Patients should discuss these options with their fertility team.
  • Emotional and Psychological Preparation: Genetic testing results can be difficult to process, especially if abnormalities are identified. Patients are encouraged to prepare emotionally and seek counseling if needed.

Related Treatments and Alternatives

Related Genetic Testing Options :
  • PGT-M (Preimplantation Genetic Testing for Monogenic Disorders): While PGT-A screens for chromosomal abnormalities, PGT-M is used to detect specific genetic disorders (like cystic fibrosis or Tay-Sachs) that may be present due to family history.
  • PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements) : This testing option is recommended for individuals with known chromosomal rearrangements, such as translocations, which may increase the risk of miscarriage or genetic disorders.
  • Non-Invasive Prenatal Testing (NIPT): Following successful pregnancy, NIPT can be conducted to screen for chromosomal abnormalities in the developing fetus.

Alternative Embryo Screening Approaches :

  • While PGT-A is the standard for screening aneuploidy, emerging non-invasive options are being researched, though they are not yet as widely used or validated. Couples should discuss the range of genetic testing options with their fertility specialist to select the best approach for their needs.

India's first anonymous IVF care

80% of couples achieve their dreams with IVFPULSE, enjoying successful deliveries at 40% less cost through top doctors—always with privacy and care.

Benefits and Risks

Benefits of PGT-A

  • Increased Pregnancy Success: By selecting chromosomally normal embryos, PGT-A improves the chances of successful implantation, leading to a higher likelihood of pregnancy.
  • Reduction in Miscarriage Rates: Many miscarriages result from chromosomal abnormalities, and PGT-A helps minimize this risk by transferring only chromosomally normal embryos.
  • Fewer IVF Cycles Needed: With PGT-A, patients are more likely to achieve a successful pregnancy in fewer IVF cycles, reducing emotional stress and financial costs.
  • Increased Confidence in Single Embryo Transfer: Patients can feel more confident in transferring a single embryo, knowing it has been screened for chromosomal normality. This approach minimizes the risk of multiple pregnancies and associated complications.
  • Improved Outcomes for High-Risk Patients: PGT-A is especially beneficial for patients with advanced maternal age, recurrent pregnancy loss, or prior IVF failures, as these groups have a higher risk of aneuploidy.

Risks and Considerations

  • Accuracy Limitations: While PGT-A is highly accurate, no test is perfect. There is a small chance of false positives or false negatives, though the technology is continuously improving.
  • Impact on Embryo Viability: Although the biopsy is generally safe, there is a very small risk that it could impact embryo viability. Experienced embryologists, however, are skilled in performing biopsies with minimal risk.
  • Cost and Accessibility: PGT-A can increase the cost of IVF, as it requires advanced technology and genetic expertise. It may not be available in all fertility clinics.
  • Ethical Considerations: Some patients have ethical or religious concerns about genetic testing on embryos. It is important for individuals and couples to discuss these considerations with their doctor and make an informed decision based on their values.
  • Emotional Impact of Results: PGT-A results can be emotionally challenging, especially if there are few or no chromosomally normal embryos. Counseling and support resources are available to help patients process the outcomes.

FAQs

FAQs